Refresh

Aarti Pharmalabs Ltd. - Research Center

543748 AARTIPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Sales

373.03 356.14 358.14 374.27 1,136.98

Operating profit

88.27 73.81 76.74 76.79 231.54

Interest

4.10 3.82 4.03 5.80 14.69

Gross profit

84.37 69.99 77.57 70.99 218.13

EPS (Rs)

5.32 4.61 5.26 4.41 14.54
Quarterly  results in details
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Other income

0.20 - 4.86 - 1.28

Stock adjustment

-5.32 -6.11 -19.29 -8.70 -82.53

Raw material

191.11 196.88 193.64 210.12 689.33

Power and fuel

- - - - -

Employee expenses

34.29 29.84 31.53 30.94 91.22

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

64.68 61.72 75.52 65.12 207.42

Provisions made

- - - - -

Depreciation

16.94 16.32 15.44 14.25 41.52

Taxation

19.25 11.86 14.50 16.75 44.88

Net profit / loss

48.19 41.81 47.63 39.99 131.73

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

45.31 45.31 45.31 45.31 45.31

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

23.66 20.72 21.43 20.52 20.36

GPM (%)

22.61 - 21.37 - 19.16

NPM (%)

12.91 - 13.12 - 11.57
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com